A majority of deaths from Friedreich's ataxia are associated with heart complications. A new treatment years in the making could provide some much-needed relief.

Patient outcomes clearly show acoramidis reduces both all-cause mortality and cardiovascular hospitalizations, but the study also reinforced the importance of early diagnosis and prompt medical therapy. 
 

The new version of the PFA system is five times faster than the current catheter to improve workflow.

The TRiCares Topaz uses a unique two-stent frame valve prosthesis for better sealing and flexibility.

Bhatt describes a mix of drug, device and strategy trials pointing to advances in cardiovascular science.
 

The risk associated with under-recognized CKD emerged early, highlighting the need for screening soon after a CAD diagnosis so that cardio-renal protective drugs can be started much earlier.

The 2023 incident potentially gave an attacker access to the names, addresses and Social Security numbers of thousands of heart patients.

The approval, made as part of a special FDA pilot program, took just 50 days.

An interventional cardiologist believes he was targeted and terminated for being outspoken about a series of incidents at his hospital. 

The cardiovascular care of thousands of Missouri patients is suddenly up in the air. The heart of the issue is a practice's alleged interest in opening up a new private equity-backed clinic.